Literature DB >> 2351871

Evidence for diurnal periodicity in human cholesterol synthesis.

P J Jones1, D A Schoeller.   

Abstract

Diurnal variation in human cholesterol synthesis in the rapidly exchangeable pool was studied in six healthy normolipidemic individuals by measurement of deuterium incorporation from body water into plasma cholesterol. After oral administration of D2O, free and de-esterified plasma cholesterol and plasma water were sampled over 48 h, converted to hydrogen, and deuterium enrichment was determined by isotope ratio mass spectrometry. Deuterium enrichment changes over 4-h intervals were used to calculate fractional synthetic rate (FSR). No significant time effects were observed on plasma total cholesterol levels over the 48-h study. The highest rate of deuterium incorporation into free cholesterol occurred during early morning, whereas during afternoon and early evening incorporation rates were lower. Free cholesterol FSR values were lowest at 14:00 to 18:00 h and peaked at 06:00 h. The periodicity across timepoints was not significantly different from that of a derived sine function equation. For cholesteryl ester, FSR data showed less distinct variation over time, peaking during early morning, indicative of maximal efflux of free cholesterol to the ester pool during this period. These findings offer direct evidence for diurnal patterns in human cholesterol synthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2351871

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  28 in total

1.  Circadian rhythm of some parameters of body composition in the elderly investigated by means of bioelectrical impedance analysis.

Authors:  P Cugini; A Salandri; V Celli; R Leonetti Luparini; R De Rosa; V Marigliano
Journal:  Eat Weight Disord       Date:  2002-09       Impact factor: 4.652

2.  Courting hyperlipidemia.

Authors:  Malvinder S Parmar
Journal:  CMAJ       Date:  2004-01-06       Impact factor: 8.262

3.  Quantifying cholesterol synthesis in vivo using (2)H(2)O: enabling back-to-back studies in the same subject.

Authors:  Stephen F Previs; Ablatt Mahsut; Alison Kulick; Keiana Dunn; Genevieve Andrews-Kelly; Christopher Johnson; Gowri Bhat; Kithsiri Herath; Paul L Miller; Sheng-Ping Wang; Karim Azer; Jing Xu; Douglas G Johns; Brian K Hubbard; Thomas P Roddy
Journal:  J Lipid Res       Date:  2011-04-17       Impact factor: 5.922

Review 4.  Synthesis of fat in response to alterations in diet: insights from new stable isotope methodologies.

Authors:  M K Hellerstein
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

5.  The contribution of newly synthesized cholesterol to biliary cholesterol in healthy humans.

Authors:  J Scheibner; K Lange; K Empen; E F Stange
Journal:  Z Ernahrungswiss       Date:  1997-12

Review 6.  Pediatric Statin Administration: Navigating a Frontier with Limited Data.

Authors:  Jonathan Wagner; Susan M Abdel-Rahman
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Sep-Oct

Review 7.  Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.

Authors:  Jose Manuel Izquierdo-Palomares; Jesus Maria Fernandez-Tabera; Maria N Plana; Almudena Añino Alba; Pablo Gómez Álvarez; Inmaculada Fernandez-Esteban; Luis Carlos Saiz; Pilar Martin-Carrillo; Óscar Pinar López
Journal:  Cochrane Database Syst Rev       Date:  2016-11-26

Review 8.  Revisiting Human Cholesterol Synthesis and Absorption: The Reciprocity Paradigm and its Key Regulators.

Authors:  Peter A S Alphonse; Peter J H Jones
Journal:  Lipids       Date:  2015-11-30       Impact factor: 1.880

9.  Low dose of ROSuvastatin in combination with EZEtimibe effectively and permanently reduce low density lipoprotein cholesterol concentration independently of timing of administration (ROSEZE): A randomized, crossover study - preliminary results.

Authors:  Karolina Obońska; Michał Kasprzak; Kamila Tymosiak; Tomasz Fabiszak; Magdalena Krintus; Jacek Kubica
Journal:  Cardiol J       Date:  2020-11-17       Impact factor: 2.737

10.  Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers.

Authors:  Paul D Martin; Patrick D Mitchell; Dennis W Schneck
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.